Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer

- Consider exemestane plus ovarian function suppression for premenopausal HR + women
- Premenopausal HR + breast cancer patients should be treated with tamoxifen (10 yrs).
- Premenopausal HR + breast cancer pts may benefit from endocrine therapy and ovarian function suppression.